Literature DB >> 2004105

On the structure of immune-stimulating saponin-lipid complexes (iscoms).

G F Kersten1, A Spiekstra, E C Beuvery, D J Crommelin.   

Abstract

Immune-stimulating complexes (iscoms) are stable complexes of cholesterol, phospholipid and Quil A, a triterpene saponin mixture in the size range from 40 to 100 nm. They can be used as antigen carriers in subunit vaccines. In this paper it is demonstrated that iscoms are rigid, negatively charged vesicles in which small water soluble molecules like carboxyfluorescein cannot be retained. The negative zeta-potential prevents iscoms from aggregation. The chemical composition of iscoms in one dispersion varied considerably. A typical example of the composition of iscoms is cholesterol/phospholipid/Quil A = 1.0:1.2:6.2 by weight for the iscom matrix, that is iscoms without antigen, and 1.0:1.3:5.1 for antigen-containing iscoms. A hypothetical model for the structure of the iscom matrix and related structures is presented, based on analytical chemical, physico-chemical and electronmicroscopic data. In this model iscoms are considered to be multi-micellar structures, shaped and stabilized by hydrophobic interactions, electrostatic repulsion, steric factors and possibly hydrogen bonds. The individual micelles are relatively flat, ring-shaped structures, the center offering space for one of the two bulky sugar chains of the saponins.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2004105     DOI: 10.1016/0005-2736(91)90388-o

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  12 in total

1.  Prevention of rotavirus infections in vitro with aqueous extracts of Quillaja Saponaria Molina.

Authors:  Michael R Roner; Ka Ian Tam; Melody Kiesling-Barrager
Journal:  Future Med Chem       Date:  2010-07       Impact factor: 3.808

2.  Ultrastructural studies on scrapie prion protein crystals obtained from reverse micellar solutions.

Authors:  H Wille; S B Prusiner
Journal:  Biophys J       Date:  1999-02       Impact factor: 4.033

3.  Characterization of in vivo anti-rotavirus activities of saponin extracts from Quillaja saponaria Molina.

Authors:  Ka Ian Tam; Michael R Roner
Journal:  Antiviral Res       Date:  2011-04-23       Impact factor: 5.970

4.  Working together: interactions between vaccine antigens and adjuvants.

Authors:  Christopher B Fox; Ryan M Kramer; Lucien Barnes V; Quinton M Dowling; Thomas S Vedvick
Journal:  Ther Adv Vaccines       Date:  2013-05

5.  Induction of protective immunity against Chlamydia trachomatis genital infection by a vaccine based on major outer membrane protein-lipophilic immune response-stimulating complexes.

Authors:  J U Igietseme; A Murdin
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441

6.  Structure of immune stimulating complex matrices and immune stimulating complexes in suspension determined by small-angle x-ray scattering.

Authors:  Jan Skov Pedersen; Cristiano L P Oliveira; Henriette Baun Hübschmann; Lise Arleth; Søren Manniche; Nicolai Kirkby; Hanne Mørck Nielsen
Journal:  Biophys J       Date:  2012-05-15       Impact factor: 4.033

7.  Nanoparticulate Quillaja saponin induces apoptosis in human leukemia cell lines with a high therapeutic index.

Authors:  Kefei Hu; Saideh Berenjian; Rolf Larsson; Joachim Gullbo; Peter Nygren; Tanja Lövgren; Bror Morein
Journal:  Int J Nanomedicine       Date:  2010-02-02

8.  Functionalization of immunostimulating complexes (ISCOMs) with lipid vinyl sulfones and their application in immunological techniques and therapy.

Authors:  Teresa Cruz-Bustos; Gloria González-González; Julia Morales-Sanfrutos; Alicia Megía-Fernández; Francisco Santoyo-González; Antonio Osuna
Journal:  Int J Nanomedicine       Date:  2012-12-03

9.  Tubular immunostimulating complex based on cucumarioside A2-2 and monogalactosyldiacylglycerol from marine macrophytes.

Authors:  Eduard Y Kostetsky; Nina M Sanina; Andrey N Mazeika; Alexander V Tsybulsky; Natalia S Vorobyeva; Valery L Shnyrov
Journal:  J Nanobiotechnology       Date:  2011-09-02       Impact factor: 10.435

Review 10.  Vaccine delivery using nanoparticles.

Authors:  Anthony E Gregory; Richard Titball; Diane Williamson
Journal:  Front Cell Infect Microbiol       Date:  2013-03-25       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.